Thümmler, L.; Lindemann, M.; Horn, P.A.; Lenz, V.; Konik, M.; Gäckler, A.; Boss, K.; Theodoropoulos, F.; Besa, V.; Taube, C.;
et al. Early Treatment with Monoclonal Antibodies or Convalescent Plasma Reduces Mortality in Non-Vaccinated COVID-19 High-Risk Patients. Viruses 2023, 15, 119.
https://doi.org/10.3390/v15010119
AMA Style
Thümmler L, Lindemann M, Horn PA, Lenz V, Konik M, Gäckler A, Boss K, Theodoropoulos F, Besa V, Taube C,
et al. Early Treatment with Monoclonal Antibodies or Convalescent Plasma Reduces Mortality in Non-Vaccinated COVID-19 High-Risk Patients. Viruses. 2023; 15(1):119.
https://doi.org/10.3390/v15010119
Chicago/Turabian Style
Thümmler, Laura, Monika Lindemann, Peter A. Horn, Veronika Lenz, Margarethe Konik, Anja Gäckler, Kristina Boss, Fotis Theodoropoulos, Vasiliki Besa, Christian Taube,
and et al. 2023. "Early Treatment with Monoclonal Antibodies or Convalescent Plasma Reduces Mortality in Non-Vaccinated COVID-19 High-Risk Patients" Viruses 15, no. 1: 119.
https://doi.org/10.3390/v15010119
APA Style
Thümmler, L., Lindemann, M., Horn, P. A., Lenz, V., Konik, M., Gäckler, A., Boss, K., Theodoropoulos, F., Besa, V., Taube, C., Brenner, T., Witzke, O., Krawczyk, A., & Rohn, H.
(2023). Early Treatment with Monoclonal Antibodies or Convalescent Plasma Reduces Mortality in Non-Vaccinated COVID-19 High-Risk Patients. Viruses, 15(1), 119.
https://doi.org/10.3390/v15010119
